Conclusion Of Non-exclusive Pharmaceutical Discount Agreements According To § 130a Para. 8 Sgb V In The Way Of A So-called Open-house Model For The Active Ingredient Icatibant (atc Code According To
Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V By Way Of A So-called Open-house Model For Medicinal Products With The Trade Name Acarizax (r) (atc Code According T